Revive Therapeutics Ltd. (RVV.CX)
0.025
0.00 (0.00%)
CAD |
CNSX |
Oct 09, 16:00
Revive Therapeutics Net Income (Quarterly) : -0.5065M for March 31, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | -0.5065M |
| December 31, 2025 | -0.2387M |
| September 30, 2025 | -0.2818M |
| June 30, 2025 | -9.597M |
| March 31, 2025 | -0.5772M |
| December 31, 2024 | -0.3647M |
| September 30, 2024 | -0.4725M |
| June 30, 2024 | -2.585M |
| March 31, 2024 | -1.872M |
| December 31, 2023 | -0.7706M |
| September 30, 2023 | -0.3906M |
| June 30, 2023 | -1.193M |
| March 31, 2023 | -1.944M |
| December 31, 2022 | -1.525M |
| September 30, 2022 | -1.659M |
| June 30, 2022 | -2.816M |
| March 31, 2022 | -6.023M |
| December 31, 2021 | -4.098M |
| September 30, 2021 | -4.870M |
| June 30, 2021 | -8.852M |
| March 31, 2021 | -4.268M |
| December 31, 2020 | -2.476M |
| September 30, 2020 | -4.522M |
| June 30, 2020 | -3.048M |
| March 31, 2020 | -1.660M |
| Date | Value |
|---|---|
| December 31, 2019 | -0.3729M |
| September 30, 2019 | -0.3081M |
| June 30, 2019 | -0.4644M |
| March 31, 2019 | -0.2509M |
| December 31, 2018 | -0.3226M |
| September 30, 2018 | -0.306M |
| June 30, 2018 | -0.5137M |
| March 31, 2018 | -0.401M |
| December 31, 2017 | -0.4342M |
| September 30, 2017 | -0.442M |
| June 30, 2017 | -0.5345M |
| March 31, 2017 | -0.4527M |
| December 31, 2016 | -0.271M |
| September 30, 2016 | -0.3577M |
| June 30, 2016 | -0.5165M |
| March 31, 2016 | -0.4967M |
| December 31, 2015 | -0.8119M |
| September 30, 2015 | -0.9128M |
| June 30, 2015 | -0.5962M |
| March 31, 2015 | -0.5756M |
| December 31, 2014 | -0.4607M |
| September 30, 2014 | -0.3986M |
| June 30, 2014 | -0.3802M |
| March 31, 2014 | -0.2789M |
| December 31, 2013 | -0.5603M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| HLS Therapeutics, Inc. | -1.412M |
| Bausch Health Cos., Inc. | 359.94M |
| Cipher Pharmaceuticals, Inc. | 5.556M |
| BioSyent, Inc. | 2.849M |
| Knight Therapeutics, Inc. | -3.361M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 0.5065M |
| EPS Diluted (Quarterly) | -0.0012 |
| Enterprise Value | 10.94M |
| Earnings Yield | -101.6% |
| Normalized Earnings Yield | -38.40 |